Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01364818 · ClinicalTrials.gov registry record
Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment
A clinical trial, sponsored by University of North Carolina, Chapel Hill.
- Completed
- Registry status
- 25
- Enrollment target
NCT01364818 is a clinical trial that has completed, run by University of North Carolina, Chapel Hill. The registered enrollment target is 25 participants.
The verdict
NCT01364818 has completed, sponsored by University of North Carolina, Chapel Hill.
- COMPLETED
- Registry status
- 25 participants
- Enrollment target
Study Summary
The purpose of the proposed research is to study the potential changes in biomarkers of patients with neurodevelopmental disorders in response to treatment in clinical trials or in private psychiatry practice utilizing non-invasive psychophysiological measurements. The investigators plan to obtain psychophysical measurements throughout several periods of treatment.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 25 participants |
| Start Date | 2011-09 |
| Est. Completion | 2014-12 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01364818
The ClinicalTrials.gov registry entry for NCT01364818 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 25 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of North Carolina, Chapel Hill, which has 1,109 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01364818 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01364818 about?
NCT01364818 is a clinical study titled "Brain Connectivity in Neurodevelopmental Disorders in Response to Treatment". The purpose of the proposed research is to study the potential changes in biomarkers of patients with neurodevelopmental disorders in response to treatment in clinical trials or in private psychiatry practice utilizing non-invasive psychophysiological measurements. The investigators plan to obtain p...
What is the current status of trial NCT01364818?
This trial is currently completed. The enrollment target is 25 participants. The study started on 2011-09. Estimated completion is 2014-12.
Who is sponsoring clinical trial NCT01364818?
This trial is sponsored by University of North Carolina, Chapel Hill, which has 1,109 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.